Evidence Advisory System Briefing Notes: England by Vlad, I et al.
Vlad, I; Hawkins, B; Ettelt, S (2016) Evidence Advisory System Brief-
ing Notes: England. Working Paper. London School of Hygiene and
Tropical Medicine.
Downloaded from: http://researchonline.lshtm.ac.uk/3206867/
DOI:
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-nd/2.5/
  
 
 EAS Briefing Note 3  
 
Evidence Advisory System Briefing Notes: 
England 
 
Ioana Vlad, Ben Hawkins, Stefanie Ettelt 
November 2016 
 
London School of Hygiene and Tropical Medicine 
GRIP-Health Programme 
www.lshtm.ac.uk/groups/griphealth 
 
 
  
  
     
 
1 Evidence Advisory System - England 
Contents 
1 Introduction .............................................................................................................................................................. 2 
2 Background ............................................................................................................................................................... 3 
3 Primary decision making points for health .................................................................................................. 5 
3.1 Legislature ........................................................................................................................................................ 6 
3.2 Department of Health .................................................................................................................................. 6 
3.2.1 Arm’s-length Bodies ........................................................................................................................... 6 
3.3 Local bodies ..................................................................................................................................................... 7 
3.3.1 Clinical Commissioning Groups ..................................................................................................... 7 
3.3.2 Local authorities .................................................................................................................................. 8 
4 Entry points for research evidence ................................................................................................................. 8 
4.1 Formal Systems ................................................................................................................................................ 8 
4.2 Informal systems .......................................................................................................................................... 11 
5 Discussion ............................................................................................................................................................... 11 
6 References ............................................................................................................................................................... 12 
 
 
  
  
  
     
 
2 Evidence Advisory System - England 
 
1 Introduction 
 
 
This paper describes the evidence advisory system for health policy-making in England, a high-
income country part of the United Kingdom of Great Britain and Northern Ireland (UK), with a 
centralised national health system, the NHS. Evidence use is a prominent theme in the discourse 
of health policy-making in England, which can be traced back to the evidence-based medicine 
movement (H. Davies and Nutley 2000). There is a strong scientific tradition that has developed 
since the 18th century, bringing about a confident and pluralistic research community. These 
There has been a growing global concern for improving the use of evidence to inform health policy in 
recent years. Increasingly there is recognition that individual projects or programmes building evidence 
synthesis skills, may be limited in their effect without a broader consideration of the systems in place 
which ‘embed’ or ‘institutionalise’ evidence informed policy making practices (Alliance for Health Policy 
and Systems Research and WHO 2007).  
The GRIP-Health programme is a five year project supported by the European Research Council which 
studies the political nature of health policy to understand how to best improve the use of evidence. This 
explicitly political lens enables us to focus on the contested nature of health issues as well as the 
institutions that shape the use of evidence in health policy making. We understand institutions as 
including both formal structures and rules, as well as informal norms and practices (Lowndes and 
Roberts 2013). The GRIP-Health programme follows the World Health Organization’s view that Ministries 
of Health remain the ultimate stewards of a nation’s health, and further play a key role in providing 
information to guide health decisions (World Health Organization 2000, Alvarez-Rosette, Hawkins, and 
Parkhurst 2013). As such, GRIP-Health is particularly concerned with the structures and rules created by 
government to gather, synthesise, or otherwise provide evidence to inform policy making. 
This working paper is one of a series of six briefs covering a set of countries in which the GRIP-Health 
programme is undertaking research. This brief presents an overview of what is termed the ‘Evidence 
Advisory System’ (EAS) for health policy making within the country of interest, which is taken to 
encompass the key entry points through which research evidence can make its way into relevant health 
policy decisions. This can include both formal (government mandated) and informal structures, rules, 
and norms in place.  
Individual reports in this series can be useful for those considering how to improve evidence use in 
specific country settings, while taken together the reports identify the differences that can be seen 
across contexts, permitting reflection or comparison across countries about how evidence advisory 
systems are structured – including which responsibilities are given to different types of bodies, and how 
well evidence advice aligns with decision making authority structures.  
 
  
  
     
 
3 Evidence Advisory System - England 
activities have also contributed to the extensive research infrastructure that government has 
built over time, which is reflected in the size and diversity of the evidence advisory system. The 
main turning points for the development of this evidence infrastructure refer to: the creation of 
a government research department; the diversification of research funders and providers; the 
increased use of processes for external audit and peer review; as well as the creation of the so-
called arm’s-length bodies with a role in funding research for social policies.  Another major 
driver of evidence use was the dual agenda of modernising government through an outward 
looking, informed policy making style that explicitly sought to include research and researchers. 
It also aligned with the emphasis on performance management that has ebbed and flowed 
through the government bureaucracy since the 1980s,  giving importance to evaluation and 
performance audits for government programmes (including clinical audits in the NHS) (Nutley 
and Webb 2000). Combined, these trends have led to a prominent belief that research can 
establish “what works” in policy and that good policy-making should be informed by evidence to 
improve both policy formulation and service delivery (Nutley and Webb 2000; Mulgan and 
Puttick 2013).  
2 Background  
England has a population of 53.9 million, accounting for 85% of the entire UK population (64.1 
million) (Office for National Statistics 2013).  Similarly, England’s gross domestic product (GDP) 
represents approximately 85% of the UK GDP - out of the current of GDP per capita of US$ 
43,734 (World Bank 2016) -, which reflects, in part, its relative size within the UK (Office for 
National Statistics 2014), and classifies it as a high-income country. The current GDP per capita 
in the UK is US$ 43,734.  
The UK is a constitutional monarchy, with a bi-cameral Parliament comprised of an upper 
house, the House of Lords, and a lower house, the House of Commons, exercising legislative 
power. Both chambers are responsible for passing legislation and scrutinising the work of the 
Government. The members of the House of Commons are elected every five years.  The 
members of the House of Lords are appointed by the Sovereign at the recommendation of the 
main political parties, with the exception of a number of seats for internally elected or 
hereditary members and for Church of England representatives. The UK Government is formed 
by the political party or coalition that wins the highest number of seats in general elections (UK 
Parliament, 2015).  The Sovereign, a Queen or a King who is the Head of State, appoints the 
leader of the winning party or coalition as Prime Minister, who then appoints ministers and 
forms the Cabinet (British Monarchy 2015). 
An important characteristic of governance in England stems from the parliamentary reforms in 
the 1990s, known as “devolution”, which led to the creation of National Assemblies and 
Governments for Wales, Scotland, and Northern Ireland. England remained “undevolved”, which 
means that governance in England has remained centralised, under the authority of the UK 
Parliament and Government. However, some Government departments have England-only 
responsibilities (e.g. the Department of Health) (UK Parliament, 2015).  Concerns about the lack 
of distinction between the UK and England institutions and the fact that decisions made for 
England often also affect the other regions have been voice but are as yet unresolved (Jeffery 
2007; UK Government 2014).  
  
  
     
 
4 Evidence Advisory System - England 
The UK National Health Service (NHS) was created in 1948 following the National Health 
Service Act (1946) which first stated the still-maintained aim of providing health care services 
free at the point of delivery.  As a consequence of devolution, the UK now has four distinct 
health systems, managed by devolved bodies (Bevan et al. 2014). The NHS in England is 
financed through general taxation and national insurance contributions. Private medical 
insurance is used by approximately 13% of the population for acute elective care in the private 
sector. Primary care includes the services of general practitioners (GPs) who are the first point 
of care within the NHS. Secondary and tertiary care are provided by specialist health care 
professionals who work in acute trusts (NHS England 2014).  
Although the vast majority of the care provided in the NHS is publicly funded, there has been an 
increase in private providers as a result of Government policies pursuing a mix of private and 
public provision (Boyle 2011).  In 1997, the Labour Government set out to decentralize 
decision-making and shift responsibility towards the regional and local levels. More recently, 
the Coalition government under David Cameron initiated a set of NHS reforms that resulted in 
the Health and Social Care Act 2012. Main changes include new care commissioning rules, and 
the shifting of key governance functions from the Department of Health to NHS England and 
moving responsibility for public health and health promotion from central level to local 
authorities (Department of Health 2012).  
  
  
     
 
5 Evidence Advisory System - England 
3 Primary decision making points for health 
While there is a general use of terminology such as ‘Evidence Based Policy’ or ‘Evidence Informed Policy’ in the 
health sector, what ‘policy’ is, is all but unambiguous. ‘Policy’ can refer to a range of concepts from projects 
and programmes, to sector-specific plans, to broad statements of intent (Hogwood and Gunn 1984). Policy is 
also not the responsibility of a single body; rather, policy decisions affecting health take place across a range of 
governmental levels and authorities.   
This lack of a universal object of study complicates health policy research. However, there are some types of 
decisions common to many countries’ health sectors for which research evidence is often held as critical. This 
allows a basic classification of decision types to provide at least a starting point for comparisons/analyses of 
country evidence advisory systems, as follows: 
- Public Health and Health Promotion: Usually high level decisions affecting large segments of the 
population. Can involve agencies outside the health service and broader sectoral interests. Often the 
responsibility of national legislatures, ministries of health, or devolved authorities. Common examples 
include: tobacco control, occupational health, healthy eating, sanitation, etc. A broad range of evidence 
will be relevant to such decisions, including epidemiological, economic, social attitude, and others 
which speak to relevant decision criteria. 
- Health Service Priority Setting and Management: Decisions concerned with the allocation of resources 
across the health system or the structure of service provision and funding, including priorities within 
the system. Often the responsibility of Ministries of Health or national health services. Common 
examples: Health system priorities, health worker responsibilities, resource generation or allocation 
decisions, etc. Relevant evidence forms include health technology appraisals/assessments (HTA), 
epidemiological and clinical studies, health services research, etc. 
- Programme Planning: Decisions within the remit of specialised agencies, such as programmes 
dedicated to individual conditions (malaria, HIV, cancer, etc.). Decisions within these bodies often 
require evidence both about efficacy or cost effectiveness of different prevention and treatment 
options, but equally often are informed by locally generated data (e.g. routine data from surveillance 
or facility information). 
Service Provider Decision Making is the most specific and tailored to individual cases. It can be health 
centre or hospital policies, or individual clinician decisions about patient care. Relevant evidence may 
include specific case details or specific realities of the context as well as more top-down use of 
guidelines.  
In addition to these types of health decisions, this working paper also recognises that decision making for 
health can take place at different levels within government hierarchies, with authority for decisions, and entry 
points for evidence resting in: national level bodies, sub-national (regional) level bodies, and local level bodies 
at times. In different country settings the various decision types listed above might be addressed at any of 
these three levels or may cut across more than one level. For instance, at the national level, the MoH usually 
functions as a decision point for certain types of decisions, but movements towards de-centralisation might 
lead to the shifting of decision-making from national/federal levels to sub-national or local levels (England is a 
case study of that). This permits consideration of whether systems of evidentiary advice are well aligned with 
the decision authority structures in a setting. There can also be important considerations on the ways that 
national evidence systems link to influential non-state decision makers (e.g. development partners in low and 
middle income settings, or corporate bodies granted authority for health policy decisions).  
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3.1 Legislature 
The UK Parliament, develops the general policy direction for the NHS through primary 
legislation. It holds the Government and the NHS to account through a series of mechanisms 
such as parliamentary debates, select committees and direct questions from Members of 
Parliament (MPs), or health-related parliamentary groups, to ministers. The main select 
committees that are relevant for decision-making in relation to health policy are the House of 
Commons Health Select Committee (examining the policy, administration and expenditures of 
the Department of Health), the Public Accounts Committee, and the National Audit Office (both 
focusing on value-for-money criteria). The Public Administration Committee also reports on the 
NHS as part of its mandate to examine the quality and standards of the civil service (Boyle 2011; 
UK Parliament 2016b). Further, the Science and Technology Committee scrutinizes whether 
Government decisions are based on the best “scientific and engineering advice and evidence” 
(UK Parliament 2016b) and has played an influential role in the development of the English 
health research system (Hanney et al. 2010). 
3.2 Department of Health 
The Department of Health (DH) has overall responsibility for the NHS, public health and social 
care. The department is led by the Secretary of Health who is assisted by a minister of state for 
health, and three parliamentary under-secretaries for Public Health and Innovation, for 
Community Health and Care, and for Health. The senior management of the operational affairs 
of the DH includes a permanent secretary and several director generals, as well as the Chief 
Medical Officer mandated with providing scientific advice to the DH on public health and clinical 
quality.  The DH and the Chief Medical Officer are supported by national clinical directors and 
advisory bodies with different areas of expertise (UK Government 2015).  
Changes to the DH structure have been made frequently as part of larger reforms (the Health 
and Social Care Act, 2012), changes in government and cost saving exercises. 
3.2.1 Arm’s-length Bodies 
The DH is supported by 26 agencies and public bodies. Of these, 15 are referred to as “arm’s-
length bodies”, with different degrees of independence from government. The remaining bodies 
are advisory non-departmental public bodies, whose role is to assist the DH in “evaluating, 
investigating and supporting policy” and providing independent scientific expertise (Boyle 
2011).  However, the number and types of these bodies is changing almost continuously with 
different governments and ministers making changes to the organisational landscape of the 
health portfolio. Arm’s length bodies form a heterogeneous category, and play three main types 
of roles: regulation, establishment of  national standards, and central/secretarial services (Boyle 
2011).  The need for reform of these arm’s length bodies (sometimes also referred to as 
‘quangos’) has been highlighted, due to their general lack of consistency, coherence and 
transparency across government. Reform needs identified (including for NHS England) refer to 
developing a clear taxonomy and improving accountability mechanisms (Public Administration 
Select Committee 2015).   
The DH is supported by two executive agencies: the Medicines and Healthcare products 
Regulatory Agency, responsible for regulating medicines, medical devices and blood 
components for transfusion, and Public Health England (PHE), developing public health and 
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health promotion policy.  Established in 2013 by bringing together 70 separate bodies, PHE 
supports local authorities in promoting public health and reducing inequalities, by providing 
evidence-based and scientific expertise. It is also responsible for a number of national initiatives 
such as immunisation and screening programmes that are commissioned nationally.  
Among the arm’s length-bodies, NHS England (established in 2012 as the NHS Commissioning 
Board) is the main steering body of the NHS “providing national leadership for improving 
outcomes and driving up the quality of care” (NHS England 2014; King’s Fund 2015). It also 
commissions a number of central services, such as highly specialised services and is responsible 
for central health programming. However, the bulk of commissioning health services is 
undertaken locally through Clinical Commissioning Groups. 
The National Institute for Health and Care Excellence (NICE) is a non-departmental public body 
that provides national guidance and advice for health, public health and social care 
practitioners, as well as legally binding quality standards for the provision and the 
commissioning of these services. This includes the appraisal of new medical technologies using 
principles of cost-effectiveness (National Institute for Health and Care Excellence 2016).   
Other non-departmental public bodies have responsibilities related to health system monitoring 
and regulation, including: the Care Quality Commission (responsible for regulating the quality of 
health and social care services), and NHS Improvement, which has recently brought together 
Monitor (the financial regulator of NHS providers), the NHS Trust Development Authority, 
Patient Safety, the National Reporting and Learning System, the Advancing Change Team and 
the Intensive Support Team (NHS Improvement 2016).  
3.3 Local bodies  
As mentioned above, the most recent major reform of the NHS included devolving responsibility 
for public health from the DH to the local authorities. Since the passing of the Health and Social 
Care Act in 2012, there have been ongoing changes to commissioning services in particular 
(which were aimed to be transferred to GPs or to local authorities), thus decreasing the 
influence and the responsibility of the Secretaries of State for Health and the DH. Therefore, 
commissioning and public health decisions are currently being taken at local levels.      
3.3.1 Clinical Commissioning Groups  
The 2012 reformed abolished strategic health authorities and primary care trusts. 
Responsibility for service commissioning was mostly shifted to newly established clinical 
commissioning groups (CCGs), overseen by NHS England. CCGs are organised around GP 
practices in the area they cover, having been designed to be clinically led (Nuffield Trust, 2015). 
CCGs commission a broad range of services on behalf of their patients including mental health 
services, urgent and emergency care, elective hospital services, and community care. These can 
be provided by NHS providers or private or voluntary sector providers.  There are currently 209 
CCGs in England. CCGs are responsible for £71.9 billion in 2016/17, which approximates two 
third of the entire budget of NHS England (NHS Clinical Commissioners 2016).  
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3.3.2 Local authorities 
With the 2012 reform public health policy became a responsibility of local authorities.  Local 
authorities had held responsibility for public health in the past, although this had been moved to 
the NHS under previous governments. Public health activities at local level are supported 
nationally by Public Health England (King’s Fund 2015).  In addition to public health, local 
authorities are responsible for social care for children and adults, housing, local planning, 
consumer protection, police and fire, waste collection, libraries and education.   
4 Entry points for research evidence  
Scientific evidence plays a pivotal role in the governance of the NHS and combined with the 
substantial volume in health systems, health services and health policy research produced in the 
UK (in addition to clinical research and basic sciences) this has led to the development of a 
culture of evidence use in which the NHS aims to become, a “consistent, evidence-based whole” 
(Shergold and Grant 2008) with substantial ‘absorptive capacity’ for the publicly and privately-
funded health research (Hanney et al. 2010).    
4.1 Formal Systems  
Parliament 
Oversight of the Department of Health by the Parliament is achieved through a number of 
mechanisms (oral/written questions, departmental question times, debates, scrutiny of Bills 
and select committee hearings). Both parliamentary inquiries and responses from the 
Government are expected to include evidence, although there is typically no formal requirement 
to draw on evidence. For example, Parliamentary committees’ reports include written and oral 
(e.g. presented by summoned witnesses) evidence. There are guidelines for “giving evidence1”, 
                                                             
1 See http://www.parliament.uk/documents/commons-committees/witnessguide.pdf 
 
For research evidence to inform policy, it must have a conduit through which it can reach decision 
makers who might be usefully informed by it. There may be a wide range of structures and norms in 
place, both formal and informal, which, when taken together, form the evidence advisory system for 
health decision making. Taking as our starting point the stewardship role of Ministries of Health (and, by 
extension, national legislatures which govern ministries), we separate between  
1.  ‘Formal systems’- taken here to represent the officially mandated agencies tasked with evidence 
synthesis and provision for decision making processes. These can be within national 
governments (for example, Ministry of Health Research Departments), Semi-autonomous bodies 
(such as the National Institute of Health and Care Excellence – NICE – in the UK), or independent 
agencies, so long as they have a formal mandate to provide evidence to inform policy; and 
2. ‘Informal systems’ - representing the systems of evidence provision that are not dictated by any 
formal decree or rule to provide evidence, but which are found to play important roles in 
evidence provision. 
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but they do not refer to research evidence in particular, or make any stipulations to the sources 
and type of evidence that should be provided.  
Prior to the 2012 NHS reforms, a report from the King’s Fund suggested that Parliamentary 
accountability for the NHS reforms could be improved.  This was seen as a way of forcing 
politicians to be transparent about their reasoning for proposed changes and to demonstrate 
how such proposals were supported by evidence (Dixon and Alvarez-Rosete 2008).  In 
November 2014, the Public Administration Select Committee highlighted the need for a formal 
process of parliamentary scrutiny before major reforms, to protect against ‘continuous 
structural reforms’. Furthermore, analyses of the 2012 healthcare reforms have highlighted the 
“unsystematic use of evidence and evaluation of earlier policies” (Rutter 2012).  
Select committees such as the House of Commons Health Select Committee or the Public 
Accounts Committee play a key role in holding the government to account for its decisions, 
policies and reforms and they mostly do so by reviewing the facts that, in relation to health 
policy, often involve an assessment of the available evidence base. In its current session, the 
Health Select Committee has launched inquiries of 14 health policy topics which are as far 
ranging as the performance of maternity services, the finances of the NHS, the implications of 
the Brexit vote and planning for winter pressures in the NHS (UK Parliament 2016a).  
The House of Lords can also be involved in challenging government policy and legislative 
proposals and it often does so by reference to evidence. It also plays an important role in 
developing science policy, through its Science and Technology Select Committee, whose 
members are typically selected for their academic merits (Hanney et al. 2010). Changes in 
science policy have led to changes in the allocation of public funds for (health) research, 
including increased support for health services research (Shergold and Grant 2008; Nutley, 
Davies, and Smith 2000).   
Government  
In England, evidence production and utilisation are interdependent. Policy makers have sought 
to balance independent scientific research with needs-driven research (Shergold and Grant 
2008). The current NHS R&D strategy, under the responsibility of the DH, includes efforts to 
identify needs and priorities for research, commission research (through the NHS, Department 
of Health, the Medical Research Council and other research councils, e.g., the Economic and 
Social Research Council-ESRC), but also synthesis of research (often through systematic 
reviews), dissemination and utilisation across the NHS (Hanney et al. 2010; NIHR 2015).  
Department of Health  
The DH has a history of commissioning research on behalf of the NHS and of collaborating with 
the various government research bodies that fund clinical and other health related research.    
Following a comprehensive review of government funded research on health and health 
services (Cooksey Review), the National Institute of Health Research (NIHR) was created in 
2006. Before the NIHR, patient-based research in the NHS was conducted through a range of 
funding schemes managed by the DH including the Cochrane Collaboration, the Centre For 
Reviews and Dissemination, the Health Technology Assessment programme and the Service and 
Delivery Organisation (National Institute of Health Research 2016). The NIHR as brought these 
dispersed initiatives together into one organisation to increase the volume of applied health 
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research in the UK and coordinate research efforts through a clearer set of priorities.  Research 
funded by the NIHR aims at meeting the information needs of policy-makers, NHS managers, 
health service providers, patients and citizens.  The NIHR is directed by the Senior Management 
Team of the Science, Research and Evidence Directorate at DH.  
The NIHR runs a large number of research programmes including on health technology 
assessment, health service and delivery research, efficiency and mechanism evaluation, public 
health research, core funding for research schools in primary care, public health and social care 
research and commissioned/researcher-led calls related to research in prioritised area of care.  
Furthermore, the NIHR, through its Policy Research Programme, commissions research to meet 
the information needs of ministers and officials in the DH.  
The NIHR has brought together a number of portals that provide access to research evidence 
across the health system, including:  NHS Evidence, the University of York’s Centre for Reviews 
and Dissemination, Cochrane UK, the NIHR Journal Library and the NIHR Dissemination Centre.   
Arms’ length bodies & advisory non-departmental public bodies   
Arm’s length bodies have an important role in research utilisation in the UK. Some of them are 
explicitly set up to make decisions using research findings (e.g. NICE) as scientific advisory 
bodies (e.g., Public Health England) and evidence synthesisers (Health and Social Care 
Information Centre).   
For example, NICE uses research produced industry actors and commissions analysis from the 
NIHR HTA programme, which are then appraised and used to inform treatment coverage 
decisions and guidance for care (Hanney et al. 2010). Other arm’s length bodies such as NHS 
England and Public Health England also make use of research funded by NIHR and others. 
However, on several occasions, the evidence used and guidance produced by PHE have attracted 
substantial criticism and have undergone intense scrutiny from researchers, policy advocates 
and others (Buck 2014). 
Commissioning & Public Health Decision-making 
Evidence use to inform clinical and commissioning decisions is expected in the NHS. However, 
this is often fraught with difficulty in practice as local decision-making typically responds to 
many pressures and competing priorities, often in the absence of a firm evidence base on which 
decisions could be based.  Also, nationally produces evidence is not always relevant to local 
problems with local decision-makers having less capacity to undertake or commission their 
own local studies.  There are a number of initiatives that aim to address the challenge of making 
such as the Diagnostic Evidence Co-operatives (DECs), the Collaborations for Leadership in 
Applied Health Research and Care (CLAHRCs) or the Academic Health Science Networks. 
However, local service commissioning in particular has been identified as an area in which 
evidence (such as clinical guidelines and cost effectiveness analyses) often seen as less relevant 
to decision-making than expected. In a 2010/11 survey of local commissioners in the NHS (then 
in PCTs) about 50 % noted that clinical guidelines and cost effectiveness analysis were 
important for health care decisions, with those trained in public health more likely to use 
evidence than others (Clarke et al., 2013) 
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4.2 Informal systems  
Policy advice can come under more or less clearly established standards. NICE, for example, has 
a clear mandate and methodologies for assessing and appraising evidence (starting from a 
prioritization process). Other sources of policy advice that present evidence have a less explicit 
process of evidence production and utilisation. The UK is a leading market for and of think 
tanks, which have not only increased in influence in the UK, but also internationally. However, 
little is known about how such think tanks prioritize topics, fund their research (and the 
methodologies employed), or influence health policy-making. Research into their roles and 
biases in health policy-making is needed (Shaw et al. 2014)  
5 Discussion  
The English NHS can be considered as being at the forefront of embedding evidence in the 
health system, partly through creating an increasingly coherent national research system. Such 
a strategy included the creation of receptor organizations in the NHS, that can broker the 
evidence produced by research units housed by the NHS, universities or charities. Linking 
health research with health service delivery has been attempted several times in the English 
NHS.  
Several authors have identified that linking evidence production and utilisation with health 
service delivery has both been a strength and a weakness of the health research system in the 
UK. On the one hand, clearly defined entry points might increase the chance for utilisation of 
evidence. On the other, frequent structural reforms of the NHS often cause need for 
restructuring in evidence production and use (Hanney et al. 2010). To this date, it is unclear 
whether evidence use at local level can fit with the often central evidence “receptors”, from 
policy-makers to arm’s length bodies to the DH. The question is, then, to what extent do local 
decision-making and the (considerable influence of) NHS England and other arm’s length bodies 
align?  
An example of potential mis-alignment comes from NICE and the need for priority setting (i.e., 
rationing in the NHS). While NICE is involved in coverage decisions for single technologies, 
commissioning at the local level, where resources are notoriously scarce, means that some 
technologies either will be provided at the detriment of other patients and the system, or an 
implicit process of priority-setting takes place, despite the rigorous evidence-base for central 
decisions by NICE (Williams 2013). However, this example perhaps illustrates the limits of an 
evidence based approach to decision making, as stringent rationing of health services is unlikely 
to be acceptable to those affected by it irrespective of such decisions being based on evidence.  
The current reforms are challenging to cover due to their sheer size. As it happened in the past, 
they are expected to influence the infrastructure for evidence production and utilisation. While 
the links are clearly there, and the expectation that the health system be “evidence-based” is a 
matter of fact, entry points for evidence used in the new NHS at local level seem to lack in 
clarity.  
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